Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer

Details 詳細情報について

• CRID

  1361981469000312448

• DOI

  10.1093/annonc/mdm347

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419411423?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419411423?httpAccept=text/plain

  http://academic.oup.com/annonc/article-pdf/18/11/1810/574316/mdm347.pdf

• Data Source

  • Crossref